Prof. Dr. John B. Haanen

Chief Scientific Officer Immunotherapy

Prof. Dr. John B. Haanen is Chief Scientific Officer immunotherapy, Consultant Medical Oncologist and Staff Scientist at the Division of Molecular Oncology & Immunology, at the Netherlands Cancer Institute in Amsterdam. John also serves as Professor of Translational Immunotherapy of Cancer at Leiden University Medical Centre in the Netherlands. John received his medical degree from the University of Leiden, completed his PhD and postdoc at Leiden and the DNAX Research Institute in California, USA, followed by post-doctoral fellowship and training in medical oncology at the Netherlands Cancer Institute. His research focuses on the translation of novel immunotherapy strategies into the clinics, especially adoptive cell transfer programs, immune checkpoint blockade and biomarker research. His clinical practice is focused on melanoma and renal cell carcinoma patients. He is Editor-in-Chief of ESMO journal IOTECH, and is member of the ESMO Council. He serves on various national and international scientific advisory boards and committees, including the editorial board of Current Oncology Reports, Kidney Cancer and ESMO Open.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.